Boston Scientific Corporation Stock
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
88.72 USD | -1.50% | -2.14% | +53.47% |
12-09 | Canaccord Genuity Adjusts Price Target on Boston Scientific to $101 From $98, Keeps Buy Rating | MT |
12-04 | Boston Scientific Insider Sold Shares Worth $633,917, According to a Recent SEC Filing | MT |
Capitalization | 131B 124B 115B 102B 185B 11,096B 202B 1,425B 526B 4,553B 491B 480B 19,749B | P/E ratio 2024 * |
66.6x | P/E ratio 2025 * | 46.9x |
---|---|---|---|---|---|
Enterprise value | 138B 130B 121B 108B 195B 11,687B 213B 1,501B 554B 4,796B 517B 506B 20,802B | EV / Sales 2024 * |
8.31x | EV / Sales 2025 * | 7.23x |
Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: Boston Scientific Corporation
1 day | -1.50% | ||
1 week | -2.14% | ||
Current month | -2.14% | ||
1 month | +0.53% | ||
3 months | +8.73% | ||
6 months | +15.06% | ||
Current year | +53.47% |
Director | Title | Age | Since |
---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 59 | 2011-10-31 |
Daniel Brennan
DFI | Director of Finance/CFO | 58 | 2013-12-30 |
Jodi Eddy
CTO | Chief Tech/Sci/R&D Officer | 51 | 2020-06-30 |
Manager | Title | Age | Since |
---|---|---|---|
John Sununu
BRD | Director/Board Member | 59 | 2009-03-31 |
Michael Mahoney
CHM | Chairman | 59 | 2016-05-02 |
Edward Ludwig
BRD | Director/Board Member | 72 | 2014-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.26% | 12 M€ | +15.09% | - | |
1.98% | 1 M€ | +2.21% | - | |
1.75% | 20 M€ | +16.41% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-1.50% | -2.14% | +61.46% | +112.96% | 133B | ||
+1.49% | +1.43% | +9.69% | -15.81% | 202B | ||
-2.10% | -0.58% | +73.59% | +58.12% | 196B | ||
+2.52% | -1.58% | +8.47% | -25.88% | 166B | ||
+1.79% | +2.03% | -0.72% | -21.64% | 60.84B | ||
-1.13% | -0.25% | -12.21% | -26.78% | 43.72B | ||
-0.88% | -0.63% | +2.49% | -40.65% | 42.19B | ||
+2.43% | +4.37% | +13.21% | -7.88% | 40.09B | ||
+0.81% | -1.59% | +19.53% | - | 37.12B | ||
+1.39% | -1.71% | +50.28% | -8.68% | 35.43B | ||
Average | +0.36% | -0.65% | +22.58% | +2.64% | 95.69B | |
Weighted average by Cap. | +0.28% | -0.59% | +29.80% | +15.29% |
2024 * | 2025 * | |
---|---|---|
Net sales | 16.58B 15.67B 14.54B 12.96B 23.41B 1,407B 25.65B 181B 66.72B 577B 62.26B 60.9B 2,504B | 18.62B 17.6B 16.33B 14.56B 26.3B 1,580B 28.81B 203B 74.95B 648B 69.94B 68.41B 2,813B |
Net income | 1.98B 1.87B 1.73B 1.55B 2.79B 168B 3.06B 21.55B 7.95B 68.83B 7.42B 7.26B 299B | 2.84B 2.69B 2.49B 2.22B 4.02B 241B 4.4B 30.99B 11.44B 98.99B 10.68B 10.44B 429B |
Net Debt | 6.98B 6.59B 6.12B 5.45B 9.85B 592B 10.79B 76.03B 28.07B 243B 26.19B 25.62B 1,054B | 3.89B 3.68B 3.41B 3.04B 5.5B 330B 6.02B 42.44B 15.67B 136B 14.62B 14.3B 588B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-09 | 88.72 $ | -1.50% | 4,875,082 |
24-12-06 | 90.07 $ | -0.51% | 3,302,016 |
24-12-05 | 90.53 $ | -0.34% | 4,173,475 |
24-12-04 | 90.84 $ | +0.41% | 3,507,289 |
24-12-03 | 90.47 $ | +0.04% | 3,192,033 |
Delayed Quote Nyse, December 09, 2024 at 04:00 pm
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- BSX Stock
MarketScreener is also available in this country: United States.
Switch edition